ArchiMed completed the acquisition of Cube from Creathor Ventures.

ArchiMed, a private equity firm, completed the acquisition of Cube Biotech, a biotechnology company, from Creathor Ventures, a private equity firm. Financial terms were not disclosed. “Partnering with ArchiMed will maximize Cube’s potential through better penetration of the US market, focused organic product and service expansion and the ability to leverage our knowledge and connections through acquisitions,” Barbara Maertens, Cube Co-Founder and Managing Director.